Article Review on Lymphatic Filariasis (Elephantiasis) Elimination: A public health success and development opportunity
David Molineux in his article “Lymphatic Filariasis (Elephantiasis) Elimination: A public health success and development opportunity” he bases his arguments on the approaches which have been adopted in different countries to eliminate Lymphatic Filariasis. He argues that despite of the achievements which have been made to eliminate the disease being looked down upon, the program has registered a remarkable progress from the year 2000 where treatments were 2 million to 60 million in 2002. Different countries are said to have expressed their interest in the programme and therefore expected to expand more and more.
Comparing the programme with the rest of the programmes which have been implemented to counter Lymphatic Filariasis, this article has ranked Global Programme as the most effective programme especially under pro-poor public health settings because other than fighting Lymphatic Filariasis, the program has been providing significant opportunities for other disease control programmes which enhance delivery of public health benefits in large scales.
The article has also presented this programme as beneficial because it’s easy when it comes to implementation and therefore affordable to even the poor society. Additionally, the programme has been presented as inexpensive way of health intervention that is accompanied by other benefits beyond the control of Lymphatic Filariasis disease and it’s also easily evaluated.
From the article, I have learnt that an approach to control or eliminate a certain disease can extend to control and eliminate other diseases which may not have been intended to be controlled. For that matter, in evaluation of any given disease control approach should be widened to gauge its impacts on other types of diseases.
Work cited
Molyneux, David. “Lymphatic filariasis (elephantiasis) elimination: a public health success and development opportunity.” Filaria journal 2.1 (2003): 13.